Canaccord Genuity Group initiated coverage on shares of Prestige Consumer Healthcare (NYSE:PBH – Get Rating) in a report issued on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $71.00 target price on the stock.
PBH has been the subject of several other reports. DA Davidson reissued a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Oppenheimer dropped their price objective on Prestige Consumer Healthcare to $63.00 in a report on Thursday, September 29th. Canaccord Genuity Group began coverage on Prestige Consumer Healthcare in a report on Wednesday, November 16th. They set a buy rating and a $71.00 price objective for the company. Finally, StockNews.com initiated coverage on Prestige Consumer Healthcare in a report on Wednesday, October 12th. They set a buy rating for the company. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of $68.75.
Prestige Consumer Healthcare Stock Up 2.2 %
Shares of NYSE:PBH opened at $59.75 on Thursday. Prestige Consumer Healthcare has a 52 week low of $48.51 and a 52 week high of $63.47. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.29 and a current ratio of 2.21. The company’s fifty day moving average is $53.02 and its 200-day moving average is $55.19. The company has a market capitalization of $2.96 billion, a PE ratio of 14.50, a P/E/G ratio of 1.78 and a beta of 0.55.
Hedge Funds Weigh In On Prestige Consumer Healthcare
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.